Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the Internatio... by Efficace, F, Buckstein, R, Abel, GA, Giesinger, JM, Fenaux, P, Bewersdorf, JP, Brunner, AM, Bejar, R, Borate, U, DeZern, AE, Greenberg, P, Roboz, GJ, Savona, MR, Sparano, F, Boultwood, J, Komrokji, R, Sallman, DA, Xie, Z, Sanz, G, Carraway, HE, Taylor, J, Nimer, SD, Della Porta, MG, Santini, V